InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Entera Bio Ltd.

ENTX Clue Score37
Israel Fiscal year ends December CIK 0001638097 Results filed 6 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Geno J Germano
9 Mar 2026
Director
Buy
20,000
$1.30
$26.00K
Sean Ellis
5 Mar 2026
Director
Buy
10,000
$1.23
$12.30K
Steven D Rubin
12 Feb 2026
Director
Buy
5,000
$1.49
$7.45K
Geno J Germano
10 Feb 2026
Director
Buy
20,000
$1.49
$29.80K
Haya Taitel
10 Feb 2026
Director
Buy
7,500
$1.48
$11.10K
Sean Ellis
9 Feb 2026
Director
Buy
18,000
$1.24
$22.32K
Steven D Rubin
9 Feb 2026
Director
Buy
10,000
$1.20
$12.00K
Miranda Jayne Toledano
29 Dec 2025
Chief Executive Officer
Buy
11,000
$1.81
$19.91K
Haya Taitel
12 Jan 2024
Director
Buy
9,500
$0.99
$9.41K
Haya Taitel
10 Jan 2024
Director
Buy
7,615
$0.77
$5.86K
Miranda Jayne Toledano
22 Dec 2023
Chief Executive Officer
Buy
23,952
$0.71
$17.01K
Gerald M Lieberman
22 Dec 2023
Director
Buy
23,952
$0.71
$17.01K
Haya Taitel
22 Aug 2023
Director
Buy
18,000
$0.62
$11.22K
Sean Ellis
21 Aug 2023
Director
Buy
40,000
$0.60
$24.00K
Gerald M Lieberman
21 Aug 2023
Director
Buy
20,000
$0.59
$11.78K
Miranda Jayne Toledano
4 Apr 2023
Chief Executive Officer
Buy
30,000
$1.01
$30.30K
Gerald M Lieberman
14 Nov 2022
Director
Buy indirect
4,000
$0.59
$2.36K
Gerald M Lieberman
14 Nov 2022
Director
Buy indirect
4,000
$0.56
$2.24K
Gerald M Lieberman
14 Nov 2022
Director
Buy indirect
4,000
$0.56
$2.24K
Gerald M Lieberman
14 Nov 2022
Director
Buy indirect
4,000
$0.56
$2.24K
Gerald M Lieberman
14 Nov 2022
Director
Buy
34,000
$0.57
$19.38K
Dana Yaacov-Garbeli
14 Nov 2022
Chief Financial Officer
Buy indirect
26,580
$0.54
$14.25K
Miranda Jayne Toledano
11 Nov 2022
Chief Executive Officer
Buy
50,000
$0.53
$26.59K
Sean Ellis
11 Nov 2022
Director
Buy
30,000
$0.53
$15.90K
Dana Yaacov-Garbeli
11 Nov 2022
Chief Financial Officer
Buy indirect
30,000
$0.52
$15.60K
Gerald M Lieberman
21 Jul 2022
Director
Buy
19,491
$1.68
$32.80K
Sean Ellis
21 Jul 2022
Director
Buy
14,900
$1.64
$24.41K
Phillip Schwartz
20 Jan 2022
President of R&D
Buy
10,000
$2.53
$25.25K
Ramesh Ratan
19 Jan 2022
U.S.based CFO
Buy
10,000
$2.44
$24.36K
Sean Ellis
18 Jan 2022
Director
Buy
10,000
$2.81
$28.05K
Ron Mayron
18 Jan 2022
Director
Buy
7,000
$2.80
$19.60K
Gerald M Lieberman
18 Jan 2022
Director
Buy indirect
700
$2.81
$1.97K
Gerald M Lieberman
18 Jan 2022
Director
Buy indirect
700
$2.78
$1.95K
Gerald M Lieberman
18 Jan 2022
Director
Buy indirect
700
$2.81
$1.96K
Gerald M Lieberman
18 Jan 2022
Director
Buy indirect
700
$2.80
$1.96K
Spiros Jamas
18 Jan 2022
Chief Executive Officer
Buy
10,000
$2.85
$28.50K
Miranda Jayne Toledano
14 Jan 2022
Director
Buy
6,800
$2.79
$18.97K
Yonatan Malca
13 Jan 2022
Director
Buy
7,232
$2.74
$19.82K
Gerald M Ostrov
13 Jan 2022
Director
Buy
10,000
$2.74
$27.38K
Show all 40 transactions →

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,552,577
History held since 11 Jan 2022